1810 related articles for article (PubMed ID: 12546118)
1. Study of drug resistance in previously treated tuberculosis patients in Gujarat, India.
Shah AR; Agarwal SK; Shah KV
Int J Tuberc Lung Dis; 2002 Dec; 6(12):1098-101. PubMed ID: 12546118
[TBL] [Abstract][Full Text] [Related]
2. Frequency of recurrence among MDR-tB cases 'successfully' treated with standardised short-course chemotherapy.
Migliori GB; Espinal M; Danilova ID; Punga VV; Grzemska M; Raviglione MC
Int J Tuberc Lung Dis; 2002 Oct; 6(10):858-64. PubMed ID: 12365571
[TBL] [Abstract][Full Text] [Related]
3. Results of a 12-month regimen for drug-resistant pulmonary tuberculosis.
Pérez-Guzmán C; Vargas MH; Martínez-Rossier LA; Torres-Cruz A; Villarreal-Velarde H
Int J Tuberc Lung Dis; 2002 Dec; 6(12):1102-9. PubMed ID: 12546119
[TBL] [Abstract][Full Text] [Related]
4. Influence of anti-tuberculosis drug resistance on the treatment outcome of pulmonary tuberculosis patients receiving DOTS in Riyadh, Saudi Arabia.
Singla R; Al-Sharif N; Al-Sayegh MO; Osman MM; Shaikh MA
Int J Tuberc Lung Dis; 2002 Jul; 6(7):585-91. PubMed ID: 12102297
[TBL] [Abstract][Full Text] [Related]
5. Drug-resistant tuberculosis in Budapest.
Fodor T; Vadász I; Lõrinczi I
Int J Tuberc Lung Dis; 1998 Sep; 2(9):732-5. PubMed ID: 9755927
[TBL] [Abstract][Full Text] [Related]
6. [Mycobacterium tuberculosis resistance to antitubercular agents in Antananarivo in 2000].
Ratsirahonana O; Rasolofo Razanamparany V; Rasolonavalona T; Rakotonirina V; Rakotoarisaonina A; Rakotoherisoa A; Ralamboson M; Cauchoix B; Rakotondramarina D; Ramarokoto H
Arch Inst Pasteur Madagascar; 2002; 68(1-2):44-7. PubMed ID: 12643091
[TBL] [Abstract][Full Text] [Related]
7. Treatment of isoniazid-resistant tuberculosis with isoniazid, rifampin, ethambutol, and pyrazinamide for 6 months.
Nolan CM; Goldberg SV
Int J Tuberc Lung Dis; 2002 Nov; 6(11):952-8. PubMed ID: 12475140
[TBL] [Abstract][Full Text] [Related]
8. How drug resistance emerges as a result of poor compliance during short course chemotherapy for tuberculosis.
Mitchison DA
Int J Tuberc Lung Dis; 1998 Jan; 2(1):10-5. PubMed ID: 9562106
[TBL] [Abstract][Full Text] [Related]
9. Surveillance of Mycobacterium tuberculosis drug resistance in Hong Kong, 1986-1999, after the implementation of directly observed treatment.
Kam KM; Yip CW
Int J Tuberc Lung Dis; 2001 Sep; 5(9):815-23. PubMed ID: 11573892
[TBL] [Abstract][Full Text] [Related]
10. Should we take a history of prior treatment, and check sputum status at 2-3 months when treating patients for tuberculosis?
Wilkinson D; Bechan S; Connolly C; Standing E; Short GM
Int J Tuberc Lung Dis; 1998 Jan; 2(1):52-5. PubMed ID: 9562111
[TBL] [Abstract][Full Text] [Related]
11. Drug resistance to the first line of antitubercular regimen (a preliminary report).
Varaiya A; Gogate A
Indian J Public Health; 1998; 42(4):126-30. PubMed ID: 10389525
[TBL] [Abstract][Full Text] [Related]
12. Pattern of mycobacterial resistance to four anti-tuberculosis drugs in pulmonary tuberculosis patients in the state of Qatar after the implementation of DOTS and a limited expatriate screening programme.
Al-Marri MR
Int J Tuberc Lung Dis; 2001 Dec; 5(12):1116-21. PubMed ID: 11769769
[TBL] [Abstract][Full Text] [Related]
13. A controlled clinical trial of oral short-course regimens in the treatment of sputum-positive pulmonary tuberculosis. Tuberculosis Research Centre.
Int J Tuberc Lung Dis; 1997 Dec; 1(6):509-17. PubMed ID: 9487448
[TBL] [Abstract][Full Text] [Related]
14. [Multicenter transversal study of tuberculosis and drug resistance in Madrid (October 1993-April 1994)].
Med Clin (Barc); 1996 Jan; 106(1):1-6. PubMed ID: 8750533
[TBL] [Abstract][Full Text] [Related]
15. Drug resistance of Mycobacterium tuberculosis strains isolated from patients with pulmonary tuberculosis in Archangels, Russia.
Toungoussova S; Caugant DA; Sandven P; Mariandyshev AO; Bjune G
Int J Tuberc Lung Dis; 2002 May; 6(5):406-14. PubMed ID: 12019916
[TBL] [Abstract][Full Text] [Related]
16. Tuberculosis chemotherapy and sputum conversion among HIV-seropositive and HIV-seronegative patients in south-eastern Uganda.
Bwire R; Borgdorff MW; Sticht-Groh V; Rieder HL; Kawuma HJ; Bretzel G; Rüsch-Gerdes S
East Afr Med J; 1999 Jun; 76(6):307-13. PubMed ID: 10750516
[TBL] [Abstract][Full Text] [Related]
17. Low rate of emergence of drug resistance in sputum positive patients treated with short course chemotherapy.
Int J Tuberc Lung Dis; 2001 Jan; 5(1):40-5. PubMed ID: 11263515
[TBL] [Abstract][Full Text] [Related]
18. Quality assurance programme for drug susceptibility testing of Mycobacterium tuberculosis in the WHO/IUATLD Supranational Laboratory Network: first round of proficiency testing.
Laszlo A; Rahman M; Raviglione M; Bustreo F
Int J Tuberc Lung Dis; 1997 Jun; 1(3):231-8. PubMed ID: 9432369
[TBL] [Abstract][Full Text] [Related]
19. [Simultaneous resistance to rifampicin and isoniazid in patients with pulmonary tuberculosis].
Ouedraogo M; Ouedraogo SM; Diagbouga S; Coulibaly G; Achi V; Domoua K; N'Dathz M; Yapi A
Rev Mal Respir; 2000 Apr; 17(2):477-80. PubMed ID: 10859766
[TBL] [Abstract][Full Text] [Related]
20. [Antitubercular chemotherapy].
Jouveshomme S; Dautzenberg B
Rev Mal Respir; 1997 Dec; 14 Suppl 5():S88-104. PubMed ID: 9496594
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]